iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN – Get Free Report) saw a large decrease in short interest in the month of August. As of August 14th, there was short interest totaling 3,452 shares, a decrease of 56.3% from the July 30th total of 7,895 shares. Based on an average trading volume of 4,508 shares, the short-interest ratio is currently 0.8 days. Currently, 2.3% of the shares of the stock are short sold.
iShares Neuroscience and Healthcare ETF Stock Performance
Shares of NYSEARCA IBRN traded down $1.07 during trading hours on Friday, hitting $39.23. 4,007 shares of the stock were exchanged, compared to its average volume of 2,328. The company has a market cap of $5.88 million, a PE ratio of 15.61 and a beta of 0.75. The company’s fifty day simple moving average is $38.54 and its two-hundred day simple moving average is $35.29. iShares Neuroscience and Healthcare ETF has a 1-year low of $25.00 and a 1-year high of $43.01.
About iShares Neuroscience and Healthcare ETF
Featured Stories
- Five stocks we like better than iShares Neuroscience and Healthcare ETF
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for iShares Neuroscience and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Neuroscience and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
